HHS unexpectedly canceled a meeting of the U.S. Preventive Services Task Force, prompting fears it may be dismantled following similar moves by Secretary Robert F. Kennedy Jr. at other federal health agencies.
Extracorporeal therapeutic apheresis demonstrated the ability to remove microplastic-like particles from human blood in patients with myalgic encephalomyelitis/chronic fatigue syndrome, according to a study published in Brain Medicine.
A new ESC clinical statement finds that common vaccines, including those for influenza and COVID-19, may lower cardiovascular risks such as heart attack, stroke, and heart failure, particularly in high-risk patients.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Scientists engineered E. coli to perform a synthetic chemical reaction that enables the conversion of plastic waste into the common drug paracetamol using a non-toxic, phosphate-driven process inside living cells.
Researchers project that next-generation influenza vaccines could prevent up to 3 billion infections and be cost-effective in many countries with appropriate pricing strategies.
FDA approves Ekterly (sebetralstat), the first oral on-demand treatment for hereditary angioedema, shown in trials to provide faster symptom relief and eliminate the need for injection.